These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 17342407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
    Dany M, Elston D.
    J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
    [Abstract] [Full Text] [Related]

  • 4. Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.
    Jęśko H, Wencel PL, Wójtowicz S, Strosznajder J, Lukiw WJ, Strosznajder RP.
    Mol Neurobiol; 2020 Jun; 57(6):2799-2811. PubMed ID: 32356173
    [Abstract] [Full Text] [Related]

  • 5. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis.
    Han X, M Holtzman D, McKeel DW, Kelley J, Morris JC.
    J Neurochem; 2002 Aug; 82(4):809-18. PubMed ID: 12358786
    [Abstract] [Full Text] [Related]

  • 6. Deregulation of sphingolipid metabolism in Alzheimer's disease.
    He X, Huang Y, Li B, Gong CX, Schuchman EH.
    Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
    [Abstract] [Full Text] [Related]

  • 7. Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.
    Fonteh AN, Ormseth C, Chiang J, Cipolla M, Arakaki X, Harrington MG.
    PLoS One; 2015 Mar; 10(5):e0125597. PubMed ID: 25938590
    [Abstract] [Full Text] [Related]

  • 8. Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer's disease.
    Yuyama K, Mitsutake S, Igarashi Y.
    Biochim Biophys Acta; 2014 May; 1841(5):793-8. PubMed ID: 23948264
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modulation of sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle.
    Obanda DN, Yu Y, Wang ZQ, Cefalu WT.
    J Nutr Biochem; 2015 Jul; 26(7):687-95. PubMed ID: 25771159
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.
    Mizuno S, Ogishima S, Kitatani K, Kikuchi M, Tanaka H, Yaegashi N, Nakaya J.
    PLoS One; 2016 Jul; 11(2):e0148431. PubMed ID: 26849355
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?
    Mielke MM, Lyketsos CG.
    Neuromolecular Med; 2010 Dec; 12(4):331-40. PubMed ID: 20571935
    [Abstract] [Full Text] [Related]

  • 20. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M, Roussos P, McKenzie A, Zhou X, Kajiwara Y, Brennand KJ, De Luca GC, Crary JF, Casaccia P, Buxbaum JD, Ehrlich M, Gandy S, Goate A, Katsel P, Schadt E, Haroutunian V, Zhang B.
    Genome Med; 2016 Nov 01; 8(1):104. PubMed ID: 27799057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.